Gene · 3134
Papers1,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic profiling of SARS-CoV-2 structural protein-specific T cell epitopes in Omicron infections following inactivated vaccination. | iScience | 2026 | 41736866 | PubTator, text mining | PubMed |
| Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry. | Front Immunol | 2026 | 41716415 | PubTator, text mining | PubMed |
| Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy. | Immun Inflamm Dis | 2026 | 41699399 | PubTator, text mining | PubMed |
| Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway. | J Immunother Cancer | 2026 | 41692513 | PubTator, text mining | PubMed |
| Retinoids enhance NK effector function against HIV-infected CD4 T cells. | J Virol | 2026 | 41589894 | PubTator, text mining | PubMed |
| Turning heterogeneity of statistical epistasis networks to an advantage. | Brief Bioinform | 2026 | 41554049 | PubTator, text mining | PubMed |
| HLA-F: A Non-Classical Gene With Growing Interest. | HLA | 2026 | 41537416 | PubTator, text mining | PubMed |
| Nonclassical HLA and pseudogenes in maternal-fetal tolerance and cancer. | Trends Immunol | 2026 | 40973530 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa. | Front Immunol | 2025 | 41766817 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| Emerging roles of natural killer cell ligands-HLA-E, HLA-F, HLA-G, MICA, and MICB-in in vitro fertilization outcomes. | Front Genet | 2025 | 41321564 | PubTator, text mining | PubMed |
| Crosstalk between decidual natural killer cells and extravillous trophoblasts at the maternal-fetal interface: current status and future perspectives. | Front Immunol | 2025 | 41200190 | PubTator, text mining | PubMed |
| Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids. | Nat Commun | 2025 | 41006208 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptomics and Mendelian randomization identify neutrophil-associated biomarker genes in colorectal cancer. | Discov Oncol | 2025 | 40996626 | PubTator, text mining | PubMed |
| Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases. | Immunol Res | 2025 | 40900356 | PubTator, text mining | PubMed |
| Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development. | Discov Oncol | 2025 | 40888998 | PubTator, text mining | PubMed |
| Pan-cancer analysis of PTPN6: prognostic significance and functional implications in tumor progression. | Discov Oncol | 2025 | 40853435 | PubTator, text mining | PubMed |
| Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection. | Elife | 2025 | 40838493 | PubTator, text mining | PubMed |
| Revealing the impact of Pseudomonas aeruginosa quorum sensing molecule 2'-aminoacetophenone on the human bronchial-airway epithelium and pulmonary endothelium using a human airway-on-a-chip. | Front Immunol | 2025 | 40735328 | PubTator, text mining | PubMed |
| Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer. | Front Immunol | 2025 | 40735323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3134/papers?page=2